Patch Pump and High Volume Injection Systems

Advances in wearable drug delivery, this conference will review the current trends in the market and highlight the latest technology in this fast growing area.

Conference Overview

The first “wearable” drug delivery device was developed in the early 1960s, a backpack which delivered insulin to the wearer. Smaller, more conveniently wearable, syringe-drivers were developed over the following decades for delivery of insulin. These type of devices are now universally known as insulin pumps and the latest versions are stuck directly onto the skin and controlled wirelessly. Ambulatory syringe drivers and bladder pumps are also used for chemotherapy and analgesia.

From the 1980s onwards, wearable passive transdermal patches were developed for dosing a range of drugs such as hormones, analgesics, anti-hypertensives and nicotine to aid smoking cessation. Recently there has been emphasis on development of wearable pumps to deliver larger volumes of biologic drugs, which would be inconvenient to deliver by self-injection.

Why you should attend:

  • Emerging trends for novel drug delivery systems
  • Understanding the market for wearable large volume injectors
  • Assessing injection site pain
  • Challenges with high volume and high viscous drug formulations
  • Demand for large volume Injectors
  • Advances in patch pump technology
  • Patch pumps and large volume injectors for volumes from 1 to 20 mL n Enterprise connected health and wearable drug delivery
  • Drug delivery solutions for advanced biologics
  • Advances in fill and finish process for biotech products
  • Challenges of medication delivery in acute and chronic care settings n Implications for device design for increasing dose volume
  • Low power wireless for drug delivery applications

Who Should Attend

This conference will be beneficial to all those who are interested in learning about, developing or sourcing wearable drug delivery devices. This includes pharmaceutical, medical device and drug delivery companies both large and small. The conference will be of particular interest to R&D, technical, medical, clinical, operating and marketing functions at all levels of management within these organisations.

Programme at a glance...

Day 1

Chairman’s welcome and introduction

Emerging trends for novel drug delivery systems

Understanding the market for wearable large volume injectors

Assessing injection site pain

Challenges with high volume and high viscous drug formulations

Demand for large volume injectors

Advances in patch pump technology

Patch pumps and large volume injectors for volumes from 1 to 20 ml

Panel discussion: The challenges associated with large volume injectors

Drinks reception

Day 2

Review of day one

Enterprise connected health and wearable drug delivery

Advances in the fill and finish process for biotech products

Drug delivery solutions for advanced biologics

Challenges of medication delivery in acute and chronic care settings – Implications for delivery device design

Planned changes to the 11608 series of ISO standards and their implications for wearable injectors

Low power wireless for drug delivery applications

Panel discussion: Large volume injections: the opportunity for connected devices

Continuing professional development

This course qualifies for the following CPD programmes:

  • Certificate

Book now

We do not currently have dates confirmed for this course; please contact us to be informed when it is scheduled; or to discuss running this course on an in-house basis for your staff.

You may also be interested in

Previous customers include...

  • 3P Innovation Ltd
  • Aptar France SAS
  • Ares Trading SA
  • Celanese
  • DCA Design International
  • LEO Pharma
  • MSD Animal Health
  • Nemera
  • Nemera La Verpilliere
  • Nordic Semiconductor
  • OnDrugDelivery Ltd
  • Owen Mumford Ltd
  • Pfizer Limited
  • Raumedic AG
  • SHL Group
  • Sonceboz SA
  • West Pharmaceutical Services

Too commercial. Too wide and diverse in subject matters

Michael McGowan, Market Intelligence Director, SHL Group

Overall excellent, friendly and lively format and experience

Pierre Carlotti, VP Strategic Marketing, Aptar France SAS

Diverse - good, well balanced in content and length

Daniel Abrahamsson, Senior Device Engineer, LEO Pharma